Preclinical haematological profile studies of an ayurvedic medicine ajowan after chronic administration to male Sprague-Dawley rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20261114Keywords:
Ajowan, Ajwain, Trachyspermum ammi, Hematological profile, Ayurvedic medicine, Preclinical safetyAbstract
Background: Ayurvedic medicines are widely utilized for their therapeutic potential, yet many remain insufficiently evaluated for safety. Ajowan (Trachyspermum ammi Linn.), a traditional remedy for gastrointestinal disturbances, is commonly used in South Asia. However, data on its haematological safety following prolonged use are scarce. This study aimed to assess the haematological effects of chronic ajowan administration in male Sprague-Dawley rats.
Methods: Eighteen healthy male Sprague-Dawley rats were randomized into three groups: control (n=8), low-dose ajowan (JAN) (50 mg/kg; n=5), and high-dose ajowan (JAN) (400 mg/kg; n=5). The extract was administered orally for 28 days. On day 29, blood samples were collected and haematological parameters- including red and white blood cell indices, platelet counts, and erythrocyte sedimentation rate (ESR), were analysed using a CELL-DYN 3700 haematology analyser.
Results: Chronic ajowan administration produced dose-related, though mostly statistically insignificant, changes in red cell indices, with slight increases in RBC, haemoglobin, and haematocrit values. White blood cell counts increased by 21.1% (low dose) and 32.8% (high dose; p=0.039), suggesting mild immunostimulation. Differential counts revealed decline in eosinophil and neutrophil, while lymphocytes and monocytes rose slightly. Platelet counts fell modestly (−2.5% at low-dose and −10.2% at high-dose), but platelet indices and ESR largely remained within normal ranges. No marked hemotoxic effects were observed.
Conclusions: Chronic ajowan administration did not induce significant haematological toxicity in male rats, though elevated WBC counts and mild platelet reductions warrant further study.
References
Verma SK, Pandey M, Sharma A, Singh D. Exploring Ayurveda: principles and their application in modern medicine. Bull Natl Res Cent. 2024;48:77.
Chrysant SG, Chrysant GS. Herbs used for the treatment of hypertension and their mechanism of action. Curr Hypertens Rep. 2017;19(9):1-10.
Naaz A, Wani GN, Begum W, Fathima S. Therapeutic potential of Nankhawah/Ajwain (Tracyspermum ammi Linn): a comprehensive review article. J Drug Deliv Ther. 2024;14(3):164-9.
Ullah MA, Hassan A, Hamza A. Medical Constituents of Ajwain (Trachyspermum ammi) for Human Benefits. J Gen Med Clin Pract. 2024;7(2):1-7.
Bairwa R, Sodha RS, Rajawat BS. Trachyspermum ammi. Pharmacogn Rev. 2012;6(11):56-60.
Parvin A, Azad MA, Sarker A, Khan MAA, Jahan N, Nadvi MR, et al. Effect on liver function of an ayurvedic medicine Punarnavasava after 28 days chronic toxicity studies on male Sprague Dawley rats. Int J Basic Clin Pharmacol. 2025;14(5):673-8.
Stevens KR, Gallo MA. Practical considerations in the conduct of chronic toxicity studies. Principles and Methods of Toxicology. New York, NY: Raven Press. 1989:237-50.
Amin MT, Fatema K, Karmakar P, Rahman MA, Haque T, Choudhuri MSK. Investigation of hemotoxicologic potential of an Ayurvedic preparation Kutajarista used in Sprue syndrome after chronic administration to male Sprague Dawley rats. Afr J Pharm Pharmacol. 2020;14(8):308-15.
Wolford ST, Schroer RA, Gohs FX, Gallo PP, Brodeck M, Falk HB, et al. Reference range database for serum chemistry and hematology values in laboratory animals. J Toxicol Environ Health. 1986;18(2):161-88.
Suljevic E, Fazlic M, Coric J, Kiseljakovic E. Evaluation of haematology analyzer CELL DYN 3700 SL. Bosn J Basic Med Sci. 2003;3(2):35-41.
Wintrobe MM. The volume and hemoglobin content of the red blood corpuscle: simple method of calculation, normal findings, and value of such calculations in the anemias. Am J Med Sci. 1929;177:513-23.
Azad MA, Ohidullah M, Neon MN, Sikder MM, Choudhuri MSK. Preclinical hematological profile studies of an ayurvedic medicine Krishna Chaturmukha after chronic administration to male Sprague-Dawley rats. Int J Basic Clin Pharmacol. 2025;14:154-9.
Westergren A. Diagnostic tests: the erythrocyte sedimentation rate range and limitations of the technique. Triangle. 1957;3(1):20-5.
Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 2000;32(1):56-67.
Arika WM, Nyamai DW, Musila MN, Ngugi MP, Njagi ENM. Hematological markers of in vivo toxicity. J Hematol Thrombo Dis. 2016;4(2):1-7.
Bloom JC, Lewis HB, Sellers TS, Deldar A. The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man. Toxicol Appl Pharmacol. 1987;90(1):135-42.
Saidani O, Umer M, Alturki N, Alshardan A, Kiran M, Alsubai S, et al. White blood cells classification using multi-fold pre-processing and optimized CNN model. Sci Rep. 2024;14:1-14.
Chan SHT, Tsung Y, Zhang Z, Chang L, Guo C, Bo Y, et al. Total and differential white blood cell count and cause‑specific mortality in 436750 Taiwanese adults. Nutr Metab Cardiovasc Dis. 2022;32(4):937-47.
Chen Y, Zhong H, Zhao Y, Luo X, Gao W. Role of platelet biomarkers in inflammatory response. Biomark Res. 2020;8:1-7.
Navaneethan U. Diagnosis of pouch disorders: laboratory tests. Pouchitis and Ileal Pouch Disorders: A Multidisciplinary Approach for Diagnosis and Management. London: Academic Press. 2019;237‑46.
Wang H, Chen Y, Wang L, Liu Q, Yang S, Wang C. Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Front Pharmacol. 2023;14:1-16.
Downloads
Published
How to Cite
Issue
Section
